Produced from a full-spectrum cranberry blend, Flowens® has been clinically shown to improve lower urinary tract symptoms (LUTS) in men at daily doses of 250mg and 500mg. The most common LUTS include difficulties associated with voiding the bladder and storage of urine. Prevalence increases with age: it is found among 26% of men in their 40s, and 90% in their 80s.
Following a recent clinical study, the use of Flowens® has been extended to women, with results showing improvement in overactive bladder (OAB) symptom at a daily dose of 500mg. OAB is the presence of urinary urgency, usually accompanied by frequency and nocturia (waking up during the night to urinate). Prevalence of OAB ranges from 9%-43% in women.
Flowens® taps into growing consumer demand for non-pharmaceutical, natural solutions that address urinary symptoms.
Dan Souza, Global Product Manager, said: “We’re delighted Flowens® has been chosen as Ingredient of Year – Healthy Ageing. The likelihood of being affected by urinary symptoms greatly increases as we get older. In fact, for many, suffering from bladder symptoms is not a matter of ‘if’ but ‘when’. Flowens® is a natural, clean-label solution for urinary symptoms that could improve the quality of life for millions of people worldwide.”
Flowens® is proven to be safe with no side-effects and is further supported by seven approved health claims related to prostate and lower urinary tract health – six from Health Canada and one from the Colombia National Food and Drug Surveillance Institute (INVIMA).